Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain-Reference-Cited by-同舟云学术

Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain

Published:2023-02 Issue: Volume:139 Page:109054
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Villanueva Vicente,Serratosa José M.,Toledo Manuel,Ángel Calleja Miguel,Navarro Andrés,Sabaniego Joel,Pérez-Domper Paloma,Álvarez-Barón Elena,Subías Silvia,Gil Alicia

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference55 articles.

1. WHO. Epilepsy 2019. https://www.who.int/en/news-room/fact-sheets/detail/epilepsy [accessed March 9, 2021].

2. The Epidemiology of Epilepsy;Beghi;Neuroepidemiology,2020

3. Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study;Serrano-Castro;Sci World J,2015

4. FEEN: Informe sociosantario FEEN sobre la epilepsia en España;García-Ramos;Neurologia,2011

5. Overview of drugs used for epilepsy and seizures: Etiology, diagnosis, and treatment;Goldenberg;P T,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam;Epilepsia Open;2024-06-11

2. Cenobamate Plasma Levels in Patients with Epilepsy: Correlation with Efficacy and Tolerability?;Journal of Clinical Medicine;2024-05-08

3. Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials;eClinicalMedicine;2024-04

4. Focal Onset Seizures: New Treatment Options in The Clinical Practice;EMJ Neurology;2023-08-15

5. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA);Epilepsy & Behavior;2023-08